Psoriatic Arthritis Clinical Trials in Tucson, Arizona

4 studies are recruiting for psoriatic arthritis in Tucson, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

    Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120), Tucson, Arizona
    Locations
    50 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07486960 on ClinicalTrials.gov

  2. A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

    Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ, Tucson, Arizona
    Locations
    123 in total
    Run by
    Takeda

    See if you can join NCT06671496 on ClinicalTrials.gov

  3. Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

    Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) tr…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Jeffrey Loomer, MD Arizona Arthritis & Rheumatology Research, Tucson, Arizona
    Locations
    78 in total
    Run by
    Takeda

    See if you can join NCT07286058 on ClinicalTrials.gov

  4. A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

    The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast, Tucson, Arizona
    Locations
    55 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06864026 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.